Skip to main content
. 2019 Dec 2;2(6):e201900603. doi: 10.26508/lsa.201900603

Figure S6. IC-50 for overlapping target kinases for different circadian period–lengthening compounds.

Figure S6.

IC-50 values (μM) were calculated from 10-dose inhibition curves (threefold serial dilution starting at 100 μM) obtained in “HotSpot” radiometric assays. Staurosporine (a potent broad spectrum protein kinase inhibitor) was used for a comparative analysis.